Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Absinthium, derived from the perennial herb *Artemisia absinthium* (commonly known as wormwood), is traditionally used in various cultures for its medicinal properties, including the treatment of digestive disorders and diabetes. In clinical and in vitro research, absinthium extracts have been evaluated for their antioxidant capacity and potential antidiabetic effects. Studies have shown that while absinthium contains significant phenolic compounds and exhibits radical scavenging activity against DPPH and hydrogen peroxide, it may not significantly inhibit glucose diffusion across the gastrointestinal tract in certain in vitro models. It is also historically significant as a primary ingredient in the spirit absinthe.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on absinthium.